×
返回 Agenda
Session 3 : Regulatory Science Strategies and Case Study for Innovative Drug Development
Session Chair(s)
Youngju Choi, PHD
Director General of Biopharmaceutical & Herbal Medicine Evaluation Department
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Sora Lee, MBA, MPHARM, RPH
Vice President, General Manager Korea
Syneos Health Inc., Korea, Republic of
Speaker(s)
Session 3 - 1
Ohseok Kwon, PHD
Ministry of Food and Drug Safety, Korea, Republic of
Recombinant Protein Products Division
Session 3 - 2
Radha Goolabsingh
DIA, United States
Global Regulatory Strategist
Session 3 - 3
Abhi Gupta
Syneos Health, United States
Senior Vice President, Head of Cell & Gene Therapy
D. Allen Callaway, MBA, MS
Johnson and Johnson, United States
Associate Director - Global Regulatory Affairs CMC